| TI: AIDS vaccine development in primate models
AU: Almond, N. M.; Heeney, J. L. | Pág. S133 |
| TI: Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
AU: Jacobson, M. A.; French, M. | Pág. S157 |
| TI: Alternative, cytokine-mediated host defense mechanisms against HIV infection: the concept of self-limitation of HIV replication
AU: Virelizier, J.-L. | Pág. S141 |
| TI: Antiretroviral therapy: where are we?
AU: Hammer, S. M.; Yeni, P. | Pág. S181 |
| TI: Antisen presentation and related immunological aspects of HIV-1 vaccines
AU: Steinman, R. M.; Germain, R. N. | Pág. S97 |
| TI: Can HIV be eradicated?
AU: Pantaleo, G.; Perrin, L. | Pág. S175 |
| TI: Can HIV epidemics among injection drug users be prevented?
AU: Strathdee, S. A.; Van Ameijden, E. J. C.; Mesquita, F.; Wodak, A. | Pág. S71 |
| TI: Cellular immune responses to HIV-1
AU: Johnson, R. P.; Siliciano, R. F.; McElrath, M. J. | Pág. S113 |
| TI: Clinical treatment: overview
AU: Vella, S.; Mildvan, D. | Pág. S147 |
| TI: Chemokines and coreceptors in HIV/SIV-host interactions
AU: Hoffman, T. L.; Doms, R. W. | Pág. S17 |
| TI: Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic
AU: Fleming, P. L.; Ward, J. W.; Karon, J. M.; Hanson, D. L. | Pág. S55 |
| TI: Diversity of the HIV/AIDS epidemic in Europe
AU: Hamers, F. F.; Downs, A. M.; Infuso, A.; Brunet, J.-B. | Pág. S63 |
| TI: Epidemiology: overview
AU: Buve, A.; Rogers, M. F. | Pág. S53 |
| TI: Focus and effectiveness of HIV-prevention efforts for young people
AU: Peersman, G. V.; Levy, J. A. | Pág. S191 |
| TI: Genetic and immunological host factors associated with susceptibility to HIV-1 infection
AU: Buchacz, K. A.; Wilkinson, D. A.; Krowka, J. F.; Koup, R. A. | Pág. S87 |
| TI: HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation
AU: Lukashov, V. V.; Goudsmit, J. | Pág. S43 |
| TI: Humoral immunity to HIV, SIV, and SHIV
AU: Haigwood, N. L.; Zolla-Pazner, S. | Pág. S121 |
| TI: In vivo detection and quantitation of HIV in blood and tissues
AU: Cavert, W. | Pág. S27 |
| TI: Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV
AU: Drucker, E.; Lurie, P.; Wodak, A.; Alcabes, P. | Pág. S217 |
| TI: New antiretrovirals and new combinations
AU: Havlir, D. V.; Lange, J. M. A. | Pág. S165 |
| TI: Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges
AU: Lackritz, E. M. | Pág. S81 |
| TI: Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions
AU: Ickovics, J. R.; Yoshikawa, H. | Pág. S197 |
| TI: Recent advances and remaining problems in HIV assembly
AU: Garnier, L.; Bowzard, J. B.; Wills, J. W. | Pág. S5 |
| TI: Recent HIV-prevention interventions for gay men: individual, small-group and community-based studies
AU: Kegeles, S. M.; Hart, G. J. | Pág. S209 |
| TI: Social, cultural and political aspects: overview
AU: Oakley, A.; Darrow, W. W. | Pág. S189 |
| TI: Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries
AU: Schrappe, M.; Lauterbach, K. | Pág. S231 |
| TI: The gastrointestinal tract and the pathogenesis of AIDS
AU: Veazey, R. S.; Lackner, A. A. | Pág. S35 |
| TI: Trial design in the era of highly effective antiviral drug combinations for HIV infection
AU: DeGruttola, V.; Hughes, M.; Gilbert, P.; Phillips, A. | Pág. S149 |
| TI: Vaccines and immunology: overview
AU: Stott, J.; Hu, S.-L. | Pág. S95 |
| TI: Virology: overview
AU: Luciw, P. A.; Harada, S. | Pág. S1 |